Pulmonary infections and resistance to antibiotics: recent information

References

• Hazir T, Nisar YB, Abbasi S et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2–59 months: a multicenter, double-blind, randomized, placebo-controlled trial in Pakistan. Clin. Infect. Dis. 52(3), 293–300 (2011).
   PubMed Web of Science ®Google Scholar
• Ramírez P, Ferrer M, Martí V et al. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit. Care Med. 39(10), 2211–2217 (2011).
   PubMed Web of Science ®Google Scholar
• Aliberti S, Peyrani P, Filardo G et al. Association between time to clinical stability and outcomes after discharge in hospitalized patients with community-acquired pneumonia. Chest 140(2), 482–488 (2011).
   PubMed Web of Science ®Google Scholar
• Kett DH, Cano E, Quartin AA et al. Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. Lancet Infect. Dis. 11(3), 181–189 (2011).
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Taylor JK, Singanayagam A et al. Epidemiology, antibiotic therapy, and clinical outcomes in health care-associated pneumonia: a UK cohort study. Clin. Infect. Dis. 53(2), 107–113 (2011).
   PubMed Web of Science ®Google Scholar
• Albert RK, Connett J, Bailey WC et al. COPD Clinical Research Network. Azithromycin for prevention of exacerbations of COPD. N. Engl. J. Med. 365(8), 689–698 (2011).
   PubMed Web of Science ®Google Scholar
• Chen D, Restrepo MI, Fine MJ et al. Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am. J. Respir. Crit. Care Med. 184(3), 312–316 (2011).
   PubMed Web of Science ®Google Scholar
• Esperatti M, Ferrer M, Theessen A et al. Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am. J. Respir. Crit. Care Med. 182(12), 1533–1539 (2010).
   PubMed Web of Science ®Google Scholar
• Berra L, Kolobow T. Ventilator-associated pneumonia or endotracheal tube-associated pneumonia or none of the above? Lessons learned from laboratory animal studies. Anesthesiology 111(4), 921–922; author reply 922 (2009).
   PubMedGoogle Scholar
• Terragni PP, Antonelli M, Fumagalli R et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 303(15), 1483–1489 (2010).
   PubMed Web of Science ®Google Scholar
• Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr. Opin. Infect. Dis. 22(3), 316–325 (2009).
   PubMed Web of Science ®Google Scholar
• Palmer LB, Smaldone GC, Chen JJ et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit. Care Med. 36(7), 2008–2013 (2008).
   PubMed Web of Science ®Google Scholar
• Nseir S. Aerosolized antibiotics for ventilator-associated tracheobronchitis: let’s go with the flow! Crit. Care Med. 36(7), 2191–2192 (2008).
   PubMed Web of Science ®Google Scholar
• Agrafiotis M, Siempos II, Falagas ME. Frequency, prevention, outcome and treatment of ventilator-associated tracheobronchitis: systematic review and meta-analysis. Respir. Med. 104(3), 325–336 (2010).
   PubMed Web of Science ®Google Scholar
• Ewig S, Woodhead M, Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 37(2), 214–223 (2011).
   PubMed Web of Science ®Google Scholar
• Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: we can’t get there from here. Clin. Infect. Dis. 52(8), 969–974 (2011).
   PubMed Web of Science ®Google Scholar
• Wunderink RG, Niederman MS, Kollef MH et al. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. Clin. Infect. Dis. 54(5), 621–629 (2012).
   PubMed Web of Science ®Google Scholar
• Martin-Loeches I, Díaz E, Vidaur L et al. H1N1 SEMICYUC/REIPI/CIBERES Working group. Pandemic and post-pandemic influenza A (H1N1) infection in critically ill patients. Crit. Care 15(6), R286 (2011).
   PubMed Web of Science ®Google Scholar
• Pereira JM, Moreno RP, Matos R et al. Severity assessment tools in ICU patients with 2009 Influenza A (H1N1) pneumonia. Clin Microbiol Infect. 18(10), 1040–1048 (2012).
   PubMed Web of Science ®Google Scholar
• Bonastre J, Suberviola B, Pozo JC et al. SEMICYUC-CIBERES-REIPI working group. [Extracorporeal lung support in patients with severe respiratory failure secondary to the 2010-2011 winter seasonal outbreak of influenza A (H1N1) in Spain]. Med. Intensiva 36(3), 193–199 (2012).
   PubMed Web of Science ®Google Scholar
• Kim SH, Hong SB, Yun SC et al. Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am. J. Respir. Crit. Care Med. 183(9), 1207–1214 (2011).
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C, Richard JC, Mercat A, Thiébaut AC, Brochard L. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 183(9),1200–1206 (2011).
   PubMed Web of Science ®Google Scholar
• Diaz E, Martin-Loeches I, Canadell L et al. H1N1 SEMICYUC-CIBERES-REIPI Working Group (GETGAG). Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. J. Infect. 64(3), 311–318 (2012).
   PubMed Web of Science ®Google Scholar
• Niederman MS, Berger JT. The delivery of futile care is harmful to other patients. Crit. Care Med. 38(10 Suppl), S518–S522 (2010).
   Web of Science ®Google Scholar